Editorial

https://doi.org/10.5599/admet.4.2.348

ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors

Godefridus Peters orcid.org/0000-0002-5447-2877 ; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Kin Tam ; Faculty of Health Sciences, University of Macau, Taipa, Macau

Abstract

Editorial

Keywords

ADME; DMPK; tyrosine kinase, serine-threonine kinase

Hrčak ID:

167041

URI

https://hrcak.srce.hr/167041

Publication date:

30.9.2016.

Visits: 936 *